WNK-IN-11 structure
|
Common Name | WNK-IN-11 | ||
---|---|---|---|---|
CAS Number | 2123489-30-3 | Molecular Weight | 462.4 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H21Cl2N5OS | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of WNK-IN-11WNK-IN-11 is an allosteric With-No-Lysine (WNK) kinase inhibitor, with an IC50 of 4 nM for WNK1. |
Name | WNK-IN-11 |
---|
Description | WNK-IN-11 is an allosteric With-No-Lysine (WNK) kinase inhibitor, with an IC50 of 4 nM for WNK1. |
---|---|
Related Catalog | |
Target |
IC50: 4 nM (WNK1)[1]. |
In Vitro | WNK-IN-11 (compound 11) shows IC50<2 μM in the cellular OSR1 phosphorylation assay with reasonable aqueous solubility, albeit with still rather high microsomal clearance. WNK-IN-11 shows ATP noncompetitive inhibition. When tested against a panel of 440 human kinases at 10 μM concentration, 2500-fold above enzyme IC50 value, WNK-IN-11 shows excellent selectivity with only a few significant off-target kinase inhibitions, most notably BTK and feline encephalitis virus-related (FER) kinase, neither of which are implicated for blood pressure regulation. This excellent selectivity profile is consistent with the predicted allosteric binding mode outside the highly conserved ATP-pocket[1]. |
References |
Molecular Formula | C21H21Cl2N5OS |
---|---|
Molecular Weight | 462.4 |
Storage condition | -20℃ |